Strides Arcolab gets nod to increase FII limit to 74%

05 Jul 2013 Evaluate

Bangalore-based pharma major Strides Arcolab has received its board’s approval to increase the limit of investments by Foreign Institutional Investors (FIls) in the equity share of the company from 49 per cent to 74 per cent. The company’s board gave the approval for the same on July 4. 2013.

The ceiling for investment by FIIs in the equity share of the company was capped at 49 per cent of its paid-up equity capital.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

874.55 6.05 (0.70%)
16-Dec-2025 11:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.90
Dr. Reddys Lab 1276.05
Cipla 1504.00
Zydus Lifesciences 919.95
Lupin 2085.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×